Michelangelo Fiorentino

Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center study.

Mollica V, Rizzo A, Tassinari E, Giunchi F, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F.

Anticancer Drugs. 2021 Jan 01. 32(1):74-81. PMID: 33290315

Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors.

Ambrosi F, Ricci C, Malvi D, Cillia C, Ravaioli M, Fiorentino M, Cardillo M, Vasuri F, D'Errico A.

Kidney Res Clin Pract. 2020 Dec 31. 39(4):487-494. PMID: 32855366

Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers.

Giunchi F, Massari F, Altimari A, Gruppioni E, Nobili E, Fiorentino M, Ardizzoni A.

Diagnostics (Basel). 2020 Dec 20. 10(12). PMID: 33419298

Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study.

Ricci C, Capizzi E, Giunchi F, Casolari L, Gelsomino F, Rihawi K, Natali F, Livi V, Trisolini R, Fiorentino M, Ardizzoni A.

Ther Adv Med Oncol. 2020. 12:1758835920954802. PMID: 33299472

The role of multiparametric MRI in active surveillance for low-risk prostate cancer: The ROMAS randomized controlled trial.

Schiavina R, Droghetti M, Novara G, Bianchi L, Gaudiano C, Panebianco V, Borghesi M, Piazza P, Mineo Bianchi F, Guerra M, Corcioni B, Fiorentino M, Giunchi F, Verze P, Pultrone C, Golfieri R, Porreca A, Mirone V, Brunocilla E.

Urol Oncol. 2020 Nov 12. PMID: 33191117

Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum.

Penney KL, Tyekucheva S, Rosenthal J, El Fandy H, Carelli R, Borgstein S, Zadra G, Fanelli GN, Stefanizzi L, Giunchi F, Pomerantz M, Peisch S, Coulson H, Lis RT, Kibel AS, Fiorentino M, Umeton R, Loda M.

Mol Cancer Res. 2020 Nov 09. PMID: 33168599

Pathological post-mortem findings in lungs infected with SARS-CoV-2.

Damiani S, Fiorentino M, De Palma A, Foschini MP, Lazzarotto T, Gabrielli L, Viale PL, Attard L, Riefolo M, D'Errico A.

J Pathol. 2021 01. 253(1):31-40. PMID: 32930394

The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification.

Colecchia M, Bertolotti A, Paolini B, Giunchi F, Necchi A, Paganoni AM, Ricci C, Fiorentino M, Dagrada GP.

Histopathology. 2021 Jan. 78(2):290-299. PMID: 32757426

Is There a Role for Immunotherapy in Prostate Cancer?

Rizzo A, Mollica V, Cimadamore A, Santoni M, Scarpelli M, Giunchi F, Cheng L, Lopez-Beltran A, Fiorentino M, Montironi R, Massari F.

Cells. 2020 09 08. 9(9). PMID: 32911806

Real-time Augmented Reality Three-dimensional Guided Robotic Radical Prostatectomy: Preliminary Experience and Evaluation of the Impact on Surgical Planning.

Schiavina R, Bianchi L, Lodi S, Cercenelli L, Chessa F, Bortolani B, Gaudiano C, Casablanca C, Droghetti M, Porreca A, Romagnoli D, Golfieri R, Giunchi F, Fiorentino M, Marcelli E, Diciotti S, Brunocilla E.

Eur Urol Focus. 2020 Aug 31. PMID: 32883625